Medical News

RSS

Viewpoints abound on impact of Ryan plan, government showdown

If the federal government shuts down at midnight on Friday — which seems likely unless negotiations take a sudden turn toward rationality — it will not be because of disagreements over spending. It will be because Republicans are refusing to budge on these ideological demands: No federal financing for Planned Parenthood. ... No local financing for abortion services in the District of Columbia. ... No funds for health care reform.

8 Apr 2011

Sangamo prices public offering of 6.7M shares of common stock

Sangamo BioSciences, Inc. today announced the pricing of its previously announced public offering of 6,700,000 shares of its common stock at a price to the public of $7.70 per share. The public offering is expected to close on or around Wednesday, April 13, 2011, subject to customary closing conditions.

8 Apr 2011

States mull Medicaid grants

Republicans talk a lot about how Medicaid block grants could help governors bring down their costs, but they don't talk as much about what, exactly, the states would do with them. It's not that they have no answers. Gov. Haley Barbour of Mississippi has said he'd like to provide home-based care for children with special medical needs, rather than resort to more expensive hospital care, but federal rules get in the way.

8 Apr 2011

Seventh Sense Biosystems receives Edison Gold Medal Award for Touch Activated Phlebotomy technology

Seventh Sense Biosystems, Inc., an early stage, venture-backed company developing a new generation of health diagnostics products, announced today that its Touch Activated Phlebotomy™ (TAP) technology has received the Gold Medal Award from The Edison Awards™ in the Science and Medicine - Diagnostic Aids Segment. These annual awards recognize innovation, creativity and ingenuity.

8 Apr 2011

DNA forensic test frees prisoner with life sentence after having served 18 years

In a landmark case, a prisoner with a life sentence was freed after serving 18 years in a Florida prison, based on DNA findings presented by DDC (DNA Diagnostics Center). DNA analysis and testimony provided by Dr. Julie Heinig, DDC's DNA Forensics Assistant Laboratory Director, is credited with leading to the exoneration of Derrick Williams earlier this week. DDC is the largest provider of private DNA paternity and other DNA testing in the United States and worldwide.

8 Apr 2011

Novation adds St. Jude Medical to portfolio of Cardiac Rhythm Management products

Novation, the leading health care supply contracting company, announced today the addition of St. Jude Medical (St. Paul, MN) to its portfolio of agreements for Cardiac Rhythm Management products.

8 Apr 2011

HCP closes acquisition of HCR ManorCare facilities for $6.1 billion

HCP announced that it closed the acquisition of 334 post-acute, skilled nursing and assisted living facilities of HCR ManorCare for a total consideration of $6.1 billion in cash. In connection with the closing, HCP entered into a long-term triple-net master lease under which HCR ManorCare will continue to operate the facilities.

8 Apr 2011

Amgen acquires Bergamo, expands operations in Brazil

Amgen, the world's largest biotechnology company, announced today the expansion of its operations in Brazil, including the acquisition of Bergamo, a privately-held Brazilian pharmaceutical company.

8 Apr 2011

HealthWarehouse.com implements Google Commerce Search for prescription medications

HealthWarehouse.com, Inc. a leading VIPPS accredited retail mail-order pharmacy, announced the implementation of Google's Commerce Search to help customers find prescription medications on its US website.

8 Apr 2011

Watson confirms patent challenge by Alcon for generic Vigamox

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Moxifloxacin Hydrochloride Ophthalmic Solution USP, 0.5%. Watson's Moxifloxacin Hydrochloride Ophthalmic Solution USP, 0.5% is a generic version of Alcon, Inc.'s Vigamox®, an antibiotic solution that is indicated for the treatment of bacterial conjunctivitis.

8 Apr 2011

MD+DI honors Xeridiem with 2011 Medical Design Excellence Award

Xeridiem™ Medical Devices is a recipient of MD+DI 's 2011 Medical Design Excellence Award (MDEA). This international award was for a novel chest tube, the PleuraFlow Active Tube Clearance System (PleuraFlow ATC), developed by Clear Catheter Systems and the Carbon Design Group. Xeridiem orchestrated the design and development for manufacturability, supported the regulatory submission, as well as manages the supply chain including order fulfillment.

8 Apr 2011

ViroXis' IND for EISO-derived product to treat HPV skin warts receives FDA approval

ViroXis Corporation today announced that the US Food and Drug Administration (FDA) granted approval for the Company's investigational new drug (IND) application and planned clinical development of a drug substance derived from East Indian Sandalwood oil (EISO) for the topical treatment of Human Papilloma Virus (HPV), common warts of the skin.

8 Apr 2011

Impax, Banner Pharmacaps collaborate for commercialization of softgel capsule products

Impax Laboratories, Inc. today announced that it will collaborate with Banner Pharmacaps Inc. with respect to the supply and commercialization of two softgel capsule products.

8 Apr 2011

FDA accepts Antares Pharma's Anturol NDA for filing, assigns PDUFA date

Antares Pharma, Inc. today announced the New Drug Application (NDA) for Anturol® Gel in patients with overactive bladder (OAB) was accepted for filing for review by the U.S. Food and Drug Administration (FDA). Anturol is an oxybutynin gel incorporating Antares' ATD Gel technology.

8 Apr 2011

Idenix prices underwritten registered public offering of 18 million shares of common stock

Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the pricing of an underwritten registered public offering of 18,310,000 shares of its common stock at a public offering price of $2.80 per share. All of the shares are being sold by Idenix.

8 Apr 2011

Survivors of severe critical illness requiring intensive care do not regain physical or psychological health

A unique and richly detailed long-term study of survivors of severe critical illness requiring intensive care found that even those who were previously healthy, young and working did not regain the physical or psychological health they had before their illness.

8 Apr 2011

An essential 'cookbook' for clinical trials

For academic medical faculty unfamiliar with national and international regulations, the prospect of initiating and managing a clinical trial can be intimidating. The development of protocols and case report forms, compliance with regulatory requirements, the monitoring of clinical trials as well as the responsibilities of documentation are just some of the tasks the sponsor-investigator is faced with.

8 Apr 2011

Vascular Disease Foundation invites applicants for ambassador program

If you or someone you love have been affected by vascular disease and have a willingness to help others, the Vascular Disease Foundation (VDF) is calling for applications to join its ambassador program to help promote vascular disease awareness.

8 Apr 2011

Current 'metrics' don't paint clear picture of health care quality

With a push to make hospitals and doctors more accountable for health care quality, more attention must be paid to the accuracy and reliability of measures used to evaluate caregivers, says a prominent Johns Hopkins patient safety expert.

8 Apr 2011

First Edition: April 8, 2011

Today's headlines include stories tracking the partisan negotiations surrounding a current-year spending bill. Currently at an impasse, the differences between the GOP and Democrats as well as the White House surrounds more than just the total dollar figure attached to spending cuts. It also involves controversial "policy riders." Meanwhile, without resolution, a government shutdown is just hours away.

8 Apr 2011

Medical News

Viewpoints abound on impact of Ryan plan, government showdown

Sangamo prices public offering of 6.7M shares of common stock

States mull Medicaid grants

Seventh Sense Biosystems receives Edison Gold Medal Award for Touch Activated Phlebotomy technology

DNA forensic test frees prisoner with life sentence after having served 18 years

Novation adds St. Jude Medical to portfolio of Cardiac Rhythm Management products

HCP closes acquisition of HCR ManorCare facilities for $6.1 billion

Amgen acquires Bergamo, expands operations in Brazil

HealthWarehouse.com implements Google Commerce Search for prescription medications

Watson confirms patent challenge by Alcon for generic Vigamox

MD+DI honors Xeridiem with 2011 Medical Design Excellence Award

ViroXis' IND for EISO-derived product to treat HPV skin warts receives FDA approval

Impax, Banner Pharmacaps collaborate for commercialization of softgel capsule products

FDA accepts Antares Pharma's Anturol NDA for filing, assigns PDUFA date

Idenix prices underwritten registered public offering of 18 million shares of common stock

Survivors of severe critical illness requiring intensive care do not regain physical or psychological health

An essential 'cookbook' for clinical trials

Vascular Disease Foundation invites applicants for ambassador program

Current 'metrics' don't paint clear picture of health care quality

First Edition: April 8, 2011

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News